Moneycontrol
Get App
you are here: HomeNewsBusiness
Last Updated : Dec 30, 2019 03:05 PM IST | Source: PTI

Dr Reddy's launches generic hypotensive injection in US

The company has launched generic Sodium Nitroprusside injection, 50 mg/2 ml (25 mg/ml) single-dose vial after getting approval from the United States Food and Drug Administration (USFDA), Dr Reddy's Labs said in a filing to the BSE.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Drug firm Dr Reddy's Laboratories on Monday said it has launched in the US Sodium Nitroprusside injection used for immediate reduction of blood pressure in hypertensive crises.

The company has launched generic Sodium Nitroprusside injection, 50 mg/2 ml (25 mg/ml) single-dose vial after getting approval from the United States Food and Drug Administration (USFDA), Dr Reddy's Labs said in a filing to the BSE.

The product is a generic version of Hospira Inc's Nitropress injection, 50 mg/2ml, it added.

Close

As per IQVIA Health data, Nitropress brand and generics had US sales of around USD 8 million MAT for the twelve months to October 2019, Dr Reddy's said.

Sodium Nitroprusside is indicated for the immediate reduction of blood pressure of adult and pediatric patients in hypertensive crises.

Shares of Dr Reddy's Laboratories were trading at Rs 2,902 per scrip on the BSE, up 0.25 percent from the previous close.

Exclusive offer: Use code "BUDGET2020" and get Moneycontrol Pro's Subscription for as little as Rs 333/- for the first year.

First Published on Dec 30, 2019 03:01 pm
Sections
Follow us on